420570 Stock Chart & Stats
$9290.00
-$10.00(-0.11%)
―
--
Day’s Range― - ―
52-Week Range$6,710.00 - $11,850.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
₩54.38B
Enterprise Value$36.24K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)13.5
Beta0.10
Next Earnings
Aug 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)272.72
Shares Outstanding5,847,483
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
420570 FAQ
What was J2KBIO Co., Ltd.’s price range in the past 12 months?
J2KBIO Co., Ltd. lowest stock price was $6710.00 and its highest was $11850.00 in the past 12 months.
What is J2KBIO Co., Ltd.’s market cap?
J2KBIO Co., Ltd.’s market cap is ₩54.38B.
When is J2KBIO Co., Ltd.’s upcoming earnings report date?
J2KBIO Co., Ltd.’s upcoming earnings report date is Aug 20, 2026 which is in 21 days.
How were J2KBIO Co., Ltd.’s earnings last quarter?
J2KBIO Co., Ltd. released its earnings results on May 14, 2026. The company reported $272.722 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is J2KBIO Co., Ltd. overvalued?
According to Wall Street analysts J2KBIO Co., Ltd.’s price is currently Undervalued.
Does J2KBIO Co., Ltd. pay dividends?
J2KBIO Co., Ltd. does not currently pay dividends.
What is J2KBIO Co., Ltd.’s EPS estimate?
J2KBIO Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does J2KBIO Co., Ltd. have?
J2KBIO Co., Ltd. has 5,847,483 shares outstanding.
What happened to J2KBIO Co., Ltd.’s price movement after its last earnings report?
J2KBIO Co., Ltd. reported an EPS of $272.722 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 19.466%.
Which hedge fund is a major shareholder of J2KBIO Co., Ltd.?
Currently, no hedge funds are holding shares in KR:420570
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
INBIOGEN CO., Ltd.
―
HLB Genex, Inc.
―
RPbio Inc.
―
Organoidsciences Ltd.
―
Psomagen Inc Shs Korean Depositary Receipt Repr 1 Sh
―